Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Use of Genome Editing Techniques to Produce Transgenic Farm Animals. | Adv Exp Med Biol | 2022 | 34807447 | PubTator, text mining | PubMed |
| Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. | Biomed Pharmacother | 2022 | 34801852 | PubTator, text mining | PubMed |
| Severe COVID-19 is associated with hyperactivation of the alternative complement pathway. | J Allergy Clin Immunol | 2022 | 34800432 | PubTator, text mining | PubMed |
| Vanadium as potential therapeutic agent for COVID-19: A focus on its antiviral, antiinflamatory, and antihyperglycemic effects. | J Trace Elem Med Biol | 2022 | 34798510 | PubTator, text mining | PubMed |
| Hereditary Angioedema. | Emerg Med Clin North Am | 2022 | 34782094 | PubTator, text mining | PubMed |
| Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation. | Nat Rev Immunol | 2022 | 34759348 | PubTator, text mining | PubMed |
| The effect of systemic levels of TNF-alpha and complement pathway activity on outcomes of VEGF inhibition in neovascular AMD. | Eye (Lond) | 2022 | 34750590 | PubTator, text mining | PubMed |
| The role of regulatory T cells on the activation of astrocytes in the brain of high-fat diet mice following lead exposure. | Chem Biol Interact | 2022 | 34742682 | PubTator, text mining | PubMed |
| Emerging roles of the complement system in host-pathogen interactions. | Trends Microbiol | 2022 | 34600784 | PubTator, text mining | PubMed |
| Antimelanoma Effects of Concomitant Inhibition of SIRT1 and SIRT3 in BrafV600E/PtenNULL Mice. | J Invest Dermatol | 2022 | 34597611 | PubTator, text mining | PubMed |
| Distinct Hepatic Gene-Expression Patterns of NAFLD in Patients With Obesity. | Hepatol Commun | 2022 | 34558849 | PubTator, text mining | PubMed |
| Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States. | Pharmacoecon Open | 2022 | 34532843 | PubTator, text mining | PubMed |
| C1-Inhibitor: Structure, Functional Diversity and Therapeutic Development. | Curr Med Chem | 2022 | 34348603 | PubTator, text mining | PubMed |
| Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedema. | Allergy | 2022 | 34287950 | PubTator, text mining | PubMed |
| Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study. | Allergy | 2022 | 34287942 | PubTator, text mining | PubMed |
| Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis. | Mol Psychiatry | 2022 | 34226666 | PubTator, text mining | PubMed |
| Diversity of transcriptomic microglial phenotypes in aging and Alzheimer's disease. | Alzheimers Dement | 2022 | 34223696 | PubTator, text mining | PubMed |
| Can Scoliotic Discs Be Controls for Molecular Studies in Intervertebral Disc Research? Insights From Proteomics. | Global Spine J | 2022 | 32945197 | PubTator, text mining | PubMed |
| Genetic Study of Hereditary Angioedema Type I and Type II (First Report from Iranian Patients: Describing Three New Mutations). | Immunol Invest | 2022 | 32896191 | PubTator, text mining | PubMed |
| Hereditary Angioedema Post-liver Transplant. | JPGN Rep | 2021 | 37205969 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=59